USPTFS: Hepatitis B screening
Published in JAMA Network, a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.
Dr. Bobby Lazzara: Published in JAMA Network a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.
The US Preventative Services Task Force commissioned a reaffirmation evidence update looking at any new evidence solid enough to institute a change in any prior recommendations.
Findings of the review indicated that serologic testing identifies the infection, and Current Interventions are effective for preventing perinatal transmission.
As a result the US Preventative Services Task Force reaffirmed its position that screening for hepatitis B virus provides substantial benefit in pregnant women and should be accomplished at their first prenatal visit.
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
